Qitan Technology Company

Developer of a genome sequencing technology. The company takes advantage of nanopores to sequence single nucleic acid molecules.Using innovative nanopore gene sequencing technology, it provides single-molecule sequencing capability with long reading length, real-time output of sequencing results, low single-running cost, small and convenient instrument, and cost-effective gene sequencing solution without complicated library preparation. It can directly detect the apparent modification of nucleic acids and expand the application of gene sequencing technology in cutting-edge biological research and clinical medicine such as instant diagnosis, metagenomics, epigenetics, RNA and transcriptomics.

Headquarters: China
Last Funding Type: Series A
Last Funding Date: 43964
Employee Number: 51-100
Founded Date: 1-1
Technology: genetics and genomics
Industry: Biotechnology, Health Care
Funding Status: Early Stage Venture